Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-22-032672

Options or other derivatives

  • Director acquired 1,419 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ros Matthew Director 2022-10-03 Grant or award · Stock Option (Right to Buy) +1,419 $9.08 $12,879 1,419 D
Loading xslF345X03/doc4.xml…